GlassScriptPhysician profile
Lonnie Douglas
NPI 1740506534
$17,973.42
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $753 · 2021: $279 · 2022: $96.09.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $13,793.98 | 2019 | |
| Anika Therapeutics, INC. | $1,654.23 | 2019 | |
| Depuy Synthes Sales INC. | $862.14 | 2019-2022 | |
| Stryker Corporation | $658.71 | 2019-2021 | |
| US Implant Solutions, LLC | $376.45 | 2019 | |
| Encore Medical, LP | $129.87 | 2021 | |
| Alpha Orthopedic Systems | $83.98 | 2020 | |
| Pacira Therapeutics, INC. | $68.46 | 2019-2021 | |
| Orthofix Medical, INC. | $66.82 | 2019-2022 | |
| Acumed LLC | $60.30 | 2020 | |
| Access Pro Medical, LLC | $43.01 | 2022 | |
| Si-Bone, INC. | $34.38 | 2020 | |
| Mallinckrodt Enterprises LLC | $32.42 | 2019 | |
| Kci USA, INC. | $28.71 | 2020 | |
| Paragon 28, INC. | $26.86 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $19.08 | 2019 | |
| Breg, INC | $18.50 | 2020 | |
| Osteocentric Technologies, INC. | $15.52 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lonnie Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.